Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

608
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
608
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

1.5K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.5K
Phase Transitions02:31

Phase Transitions

22.2K
Whether solid, liquid, or gas, a substance's state depends on the order and arrangement of its particles (atoms, molecules, or ions). Particles in the solid pack closely together, generally in a pattern. The particles vibrate about their fixed positions but do not move or squeeze past their neighbors. In liquids, although the particles are closely spaced, they are randomly arranged. The position of the particles are not fixed—that is, they are free to move past their neighbors to...
22.2K
Phase II Conjugation Reactions: Overview01:14

Phase II Conjugation Reactions: Overview

654
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
654
Phase Diagram01:19

Phase Diagram

6.8K
The phase of a given substance depends on the pressure and temperature. Thus, plots of pressure versus temperature showing the phase in each region provide considerable insights into the thermal properties of substances. Such plots are known as phase diagrams. For instance, in the phase diagram for water (Figure 1), the solid curve boundaries between the phases indicate phase transitions (i.e., temperatures and pressures at which the phases coexist).
6.8K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuning glass-forming dynamics by modifying hydrogen bonding: From polyalcohols to van der Waals liquids.

The Journal of chemical physics·2026
Same author

Macroscopic Illusion and Microscopic Reality of Glass Formation Paths: Cooling vs Compression.

Physical review letters·2026
Same author

Pressure-Induced Solid-Solid Phase Transitions in Barocaloric Organic Ionic Plastic Crystals.

ACS applied materials & interfaces·2026
Same author

Eutectic-Driven Recrystallization of Coamorphous Bicalutamide + Niclosamide Systems: Contrasting Stability above and below <i>T</i><sub>g</sub>.

Molecular pharmaceutics·2026
Same author

Resolving the Arrhenius Paradox by Isochoric Analysis of Rotational Barriers in Molecular Glasses.

Physical review letters·2026
Same author

Eutectic Coamorphous System of Enzalutamide and Acetyl Maltose: A Strategy for Improved Physical Stability and Aqueous Solubility.

Molecular pharmaceutics·2026

Related Experiment Video

Updated: Dec 21, 2025

High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal
06:24

High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal

Published on: October 31, 2019

6.8K

Compression-Induced Phase Transitions of Bicalutamide.

Joanna Szafraniec-Szczęsny1,2, Agata Antosik-Rogóż1, Justyna Knapik-Kowalczuk3

  • 1Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.

Pharmaceutics
|May 14, 2020
PubMed
Summary

This study explores amorphous solid dispersions of bicalutamide with PVP/VA, revealing that high polymer content enhances stability against recrystallization. These dispersions significantly improve drug dissolution and wettability compared to crystalline forms.

Keywords:
Kollidon®VA64amorphous solid dispersionsbicalutamidecompressiondissolutionphysical stability

More Related Videos

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.1K
Submillisecond Conformational Changes in Proteins Resolved by Photothermal Beam Deflection
10:02

Submillisecond Conformational Changes in Proteins Resolved by Photothermal Beam Deflection

Published on: February 18, 2014

9.3K

Related Experiment Videos

Last Updated: Dec 21, 2025

High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal
06:24

High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal

Published on: October 31, 2019

6.8K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.1K
Submillisecond Conformational Changes in Proteins Resolved by Photothermal Beam Deflection
10:02

Submillisecond Conformational Changes in Proteins Resolved by Photothermal Beam Deflection

Published on: February 18, 2014

9.3K

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science

Background:

  • Amorphous solid dispersions enhance oral absorption of poorly soluble drugs.
  • Recrystallization of amorphous drugs is a major formulation challenge.

Purpose of the Study:

  • To investigate the amorphization and recrystallization behavior of bicalutamide in amorphous solid dispersions (ASDs) with poly(vinylpyrrolidone-co-vinyl acetate) (PVP/VA).
  • To understand the factors influencing the stability of bicalutamide ASDs.

Main Methods:

  • Amorphous solid dispersions prepared by ball milling and spray drying.
  • Characterization using X-ray diffraction (XRD), differential scanning calorimetry (DSC), and infrared spectroscopy (IR).
  • Assessment of drug-polymer miscibility using non-isothermal dielectric measurements and evaluation of mechanical stability under compression.

Main Results:

  • Both ball milling and spray drying successfully produced amorphous bicalutamide.
  • Compression of physical blends induced amorphization or polymorphic transition.
  • High drug-polymer miscibility and hydrogen bond formation contributed to ASD stability.
  • ASDs showed 2.5- to 11-fold enhanced dissolution compared to crystalline bicalutamide.
  • Bicalutamide remained amorphous upon compression at PVP/VA content >20% (spray-dried) or >33% (milled).

Conclusions:

  • Amorphous solid dispersions of bicalutamide with PVP/VA offer improved dissolution and wettability.
  • The stability of ASDs against recrystallization is dependent on polymer content and preparation method.
  • Understanding amorphization-recrystallization pathways is crucial for developing stable amorphous drug formulations.